Celia D. Examining the FDA’s Drug Approvals Process. First Report.
Celia examines the complexities of the FDA’s drug approval process. In this article, the author examines the approval process using the new drug, Aducanumab, as an example. The author meticulously inspects the FDA’s drug approval process from healthcare and legislative perspectives. Additionally, in the article, Celia analyzes role of concrete data, beneficiaries, and emergency use authorization in the FDA’s drug approval process.
Read the full article here https://www.hmpgloballearningnetwork.com/site/frmc/feature-story/examining-fdas-drug-approvals-process
